KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Return on Sales: 2010-2025

Historic Return on Sales for Arbutus Biopharma (ABUS) over the last 16 years, with Sep 2025 value amounting to -2.89%.

  • Arbutus Biopharma's Return on Sales rose 848.00% to -2.89% in Q3 2025 from the same period last year, while for Sep 2025 it was -2.89%, marking a year-over-year increase of 848.00%. This contributed to the annual value of -11.33% for FY2024, which is 731.00% down from last year.
  • Latest data reveals that Arbutus Biopharma reported Return on Sales of -2.89% as of Q3 2025, which was up 17.79% from -3.52% recorded in Q2 2025.
  • Arbutus Biopharma's Return on Sales' 5-year high stood at -1.78% during Q4 2022, with a 5-year trough of -11.95% in Q1 2025.
  • In the last 3 years, Arbutus Biopharma's Return on Sales had a median value of -4.02% in 2023 and averaged -6.10%.
  • Per our database at Business Quant, Arbutus Biopharma's Return on Sales surged by 1,236bps in 2021 and then tumbled by 798bps in 2024.
  • Arbutus Biopharma's Return on Sales (Quarterly) stood at -6.94% in 2021, then surged by 516bps to -1.78% in 2022, then tumbled by 224bps to -4.02% in 2023, then crashed by 731bps to -11.32% in 2024, then spiked by 848bps to -2.89% in 2025.
  • Its last three reported values are -2.89% in Q3 2025, -3.52% for Q2 2025, and -11.95% during Q1 2025.